Evidence map›Paper›PMID 26114479›Full record

ArticlePLoS genetics2015

Context-Dependent Functional Divergence of the Notch Ligands DLL1 and DLL4 In Vivo.

Kristina Preuße, Lena Tveriakhina, Karin Schuster-Gossler, Cláudia Gaspar, Alexandra Isabel Rosa, Domingos Henrique, Achim Gossler, Michael Stauber

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Notch Signaling in the Vasculature: Angiogenesis and Angiocrine Functions.Cold Spring Harbor perspectives in medicine · 2023
    Review
  8. Review
  9. Review
  10. Article
  11. Dynamic switching of lateral inhibition spatial patterns.Journal of the Royal Society, Interface · 2022
    Article
  12. Article
  13. Review
  14. Article
  15. Biophysics of Notch Signaling.Annual review of biophysics · 2021
    Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Kristina PreußeInstitut für Molekularbiologie OE5250, Medizinische Hochschule Hannover, Hannover, Germany.
Lena TveriakhinaInstitut für Molekularbiologie OE5250, Medizinische Hochschule Hannover, Hannover, Germany.
Karin Schuster-GosslerInstitut für Molekularbiologie OE5250, Medizinische Hochschule Hannover, Hannover, Germany.
Cláudia GasparInstituto de Medicina Molecular, Faculdade de Medicina da Universidade de Lisboa, Lisboa, Portugal.
Alexandra Isabel RosaInstituto de Medicina Molecular, Faculdade de Medicina da Universidade de Lisboa, Lisboa, Portugal.
Domingos HenriqueInstituto de Medicina Molecular, Faculdade de Medicina da Universidade de Lisboa, Lisboa, Portugal.
Achim GosslerInstitut für Molekularbiologie OE5250, Medizinische Hochschule Hannover, Hannover, Germany.
Michael StauberInstitut für Molekularbiologie OE5250, Medizinische Hochschule Hannover, Hannover, Germany.
Medizinische Hochschule Hannover · DEUniversity of Lisbon · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Notch signalling is a fundamental pathway that shapes the developing embryo and sustains adult tissues by direct communication between ligand and receptor molecules on adjacent cells. Among the ligands are two Delta paralogues, DLL1 and DLL4, that are conserved in mammals and share a similar structure and sequence. They activate the Notch receptor partly in overlapping expression domains where they fulfil redundant functions in some processes (e.g. maintenance of the crypt cell progenitor pool). In other processes, however, they appear to act differently (e.g. maintenance of foetal arterial identity) raising the questions of how similar DLL1 and DLL4 really are and which mechanism causes the apparent context-dependent divergence. By analysing mice that conditionally overexpress DLL1 or DLL4 from the same genomic locus (Hprt) and mice that express DLL4 instead of DLL1 from the endogenous Dll1 locus (Dll1Dll4ki), we found functional differences that are tissue-specific: while DLL1 and DLL4 act redundantly during the maintenance of retinal progenitors, their function varies in the presomitic mesoderm (PSM) where somites form in a Notch-dependent process. In the anterior PSM, every cell expresses both Notch receptors and ligands, and DLL1 is the only activator of Notch while DLL4 is not endogenously expressed. Transgenic DLL4 cannot replace DLL1 during somitogenesis and in heterozygous Dll1Dll4ki/+ mice, the Dll1Dll4ki allele causes a dominant segmentation phenotype. Testing several aspects of the complex Notch signalling system in vitro, we found that both ligands have a similar trans-activation potential but that only DLL4 is an efficient cis-inhibitor of Notch signalling, causing a reduced net activation of Notch. These differential cis-inhibitory properties are likely to contribute to the functional divergence of DLL1 and DLL4.

Indexed as

Gene Expression Regulation, DevelopmentalAdaptor Proteins, Signal TransducingAnimalsCalcium-Binding ProteinsExtremitiesIntercellular Signaling Peptides and ProteinsIntracellular Signaling Peptides and ProteinsMembrane ProteinsMesodermMice, TransgenicProtein Structure, TertiaryReceptors, NotchRetinaSignal TransductionAdaptor Proteins, Signal TransducingCalcium-Binding ProteinsDlk1 protein, mouseDLL4 protein, mouseIntercellular Signaling Peptides and ProteinsIntracellular Signaling Peptides and ProteinsMembrane ProteinsReceptors, Notch

Identifiers

PMID26114479
PMCPMC4482573
OpenAlexW758268473

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.